Stannous Maa Kit 2.1 mg (Albumin (Human) KIT) 2.1 MG

Stannous MAA Kit 2.1 mg is a radiopharmaceutical used for diagnostic imaging. This intravenous kit contains albumin (human) and is designed for medical imaging procedures.

Strength

2.1 MG

Manufacturer / TM Owner

CALGARY RADIOPHARMACEUTICAL CENTRE / ALBERTA HEALTH SERVICES

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Stannous MAA Kit 2.1 mg is primarily used in diagnostic imaging to assess blood flow and organ function. It is often utilized in procedures that require visualization of the vascular system or specific organs. The kit is designed to be administered intravenously, making it suitable for various imaging techniques that help healthcare professionals evaluate internal structures and functions.

Side Effects

The effects of Stannous MAA Kit 2.1 mg are primarily observed during diagnostic imaging procedures. It helps in enhancing the visibility of blood vessels and organs, aiding in the accurate diagnosis of various conditions. The kit is formulated to provide clear and detailed images, which can be crucial for effective medical evaluation.

Precautions & Warnings

Handling Stannous MAA Kit 2.1 mg requires adherence to standard safety protocols for radiopharmaceuticals. It should be used under the supervision of qualified healthcare professionals. Proper storage and disposal procedures must be followed to ensure safety and efficacy. Always consult the product guidelines for specific handling instructions.

Avoid Interactions

Stannous MAA Kit 2.1 mg may interact with certain medications or substances. It is important to inform healthcare professionals about any other medications being taken to avoid potential interactions. Specific interactions should be discussed with a healthcare provider to ensure safe and effective use.

Frequently Asked Questions

Stannous MAA Kit 2.1 mg is used for diagnostic imaging to assess blood flow and organ function.

Stannous MAA Kit 2.1 mg is administered intravenously under the supervision of healthcare professionals.

The common effects include enhanced visibility of blood vessels and organs during diagnostic imaging procedures.

Yes, it should be handled and administered by qualified healthcare professionals following standard safety protocols.

Potential interactions should be discussed with a healthcare provider to ensure safe use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.